Vyome Holdings, Inc. (HIND)Healthcare | Biotechnology | Cambridge, United States | NasdaqCM
2.21 USD
-0.01
(-0.226%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 2.15 -0.05 (-0.055%) ⇩ (Aug. 28, 2026, 7:43 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 2:24 a.m. EDT
The immediate outlook is flat to slightly negative due to a lack of clear directional momentum, though the recent price action shows some minor stabilization around the $2.20 level. However, the long-term investment case is severely compromised by a catastrophic multi-year decline; the asset has lost virtually all its value over the last eight years, with four consecutive years of negative returns ending recently. This persistent downward trajectory suggests a fundamental deterioration that outweighs any potential recovery thesis. Furthermore, there is no dividend income to offset these risks, as the company has not paid any dividends in the last five years. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.037515 |
| AutoARIMA | 0.042662 |
| AutoETS | 0.042663 |
| AutoTheta | 0.042853 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 44% |
| H-stat | 1.31 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.041 |
| Excess Kurtosis | 0.92 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.237 |
| Revenue per Share | 0.018 |
| Market Cap | 15,475,854 |
| Website | https://www.vyometx.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.7410662 |
| Address1 | Harvard Square |
| Address2 | One Mifflin Place Suite 400 |
| All Time High | 138,156,000.0 |
| All Time Low | 1.75 |
| Ask | 2.81 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 8,610 |
| Average Daily Volume3 Month | 14,700 |
| Average Volume | 14,700 |
| Average Volume10Days | 8,610 |
| Bid | 1.6 |
| Bid Size | 2 |
| Book Value | 0.862 |
| City | Cambridge |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.205 |
| Current Ratio | 4.373 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 2.265 |
| Day Low | 2.205 |
| Debt To Equity | 0.237 |
| Display Name | Vyome |
| Earnings Timestamp End | 1,763,064,000 |
| Earnings Timestamp Start | 1,763,064,000 |
| Ebitda | -4,205,649 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -2.109 |
| Enterprise To Revenue | 68.367 |
| Enterprise Value | 8,868,874 |
| Eps Trailing Twelve Months | -1.61 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.17466 |
| Fifty Day Average Change | 0.030339956 |
| Fifty Day Average Change Percent | 0.013951587 |
| Fifty Two Week Change Percent | -74.10662 |
| Fifty Two Week High | 9.56 |
| Fifty Two Week High Change | -7.3550005 |
| Fifty Two Week High Change Percent | -0.7693515 |
| Fifty Two Week Low | 1.75 |
| Fifty Two Week Low Change | 0.45499992 |
| Fifty Two Week Low Change Percent | 0.25999996 |
| Fifty Two Week Range | 1.75 - 9.56 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,475,760,600,000 |
| Float Shares | 3,645,845 |
| Free Cashflow | 3,641,658 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 9 |
| Fullday Change | -0.00500011 |
| Fullday Change Percent | -0.22625 |
| Fullday Price | 2.15 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.52742 |
| Gross Profits | 68,420 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.52881 |
| Held Percent Institutions | 0.02178 |
| Implied Shares Outstanding | 7,018,528 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,755,216,000 |
| Last Split Factor | 1:4 |
| Long Business Summary | Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechnology segments. The company's lead product candidate VT-1953, a dual DNA Gyrase/Topoisomerase inhibitor and immunomodulator in a topical gel formulation that is in phase 2 clinical stage for the treatment of bacterial conjunctivitis. It also develops VT-1908, a topical eye drop is an inosine 5'-monophosphate dehydrogenase enzyme inhibitor to treat immunoinflammatory conditions of the eye; and VB-1953, which is in phase 2 clinical stage for the treatment of inflammatory acne. In addition, the company develops antifungal products using the molecular replacement therapy (MRT) platform. It has a collaboration and license agreement with Sun Pharma Laboratories Limited to develop and commercialize next-generation antifungal products. The company is based in Cambridge, Massachusetts. |
| Long Name | Vyome Holdings, Inc. |
| Market | us_market |
| Market Cap | 15,475,854 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_115222623 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -11,307,741 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 15,510,946 |
| Number Of Analyst Opinions | 2 |
| Open | 2.265 |
| Operating Cashflow | -5,578,745 |
| Operating Margins | -32.00022 |
| Payout Ratio | 0.0 |
| Phone | 973 832 8147 |
| Post Market Change | -0.05499983 |
| Post Market Change Percent | -2.4943233 |
| Post Market Price | 2.15 |
| Post Market Time | 1,787,960,623 |
| Previous Close | 2.21 |
| Price Hint | 4 |
| Price To Book | 2.5580046 |
| Price To Sales Trailing12 Months | 119.29739 |
| Profit Margins | 0.0 |
| Quick Ratio | 4.312 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0050001144 |
| Regular Market Change Percent | -0.22624952 |
| Regular Market Day High | 2.265 |
| Regular Market Day Low | 2.205 |
| Regular Market Day Range | 2.205 - 2.265 |
| Regular Market Open | 2.265 |
| Regular Market Previous Close | 2.21 |
| Regular Market Price | 2.205 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 1,518 |
| Return On Assets | -0.48791 |
| Return On Equity | -9.99174 |
| Revenue Growth | -0.46 |
| Revenue Per Share | 0.018 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 7,018,528 |
| Shares Percent Shares Out | 0.0034999999 |
| Shares Short | 24,522 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 38,719 |
| Short Name | Vyome Holdings, Inc. |
| Short Percent Of Float | 0.0054 |
| Short Ratio | 2.47 |
| Source Interval | 15 |
| State | MA |
| Symbol | HIND |
| Target High Price | 15.0 |
| Target Low Price | 8.0 |
| Target Mean Price | 11.5 |
| Target Median Price | 11.5 |
| Total Cash | 7,887,510 |
| Total Cash Per Share | 1.124 |
| Total Debt | 17,310 |
| Total Revenue | 129,725 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.61 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 2.77625 |
| Two Hundred Day Average Change | -0.57124996 |
| Two Hundred Day Average Change Percent | -0.20576316 |
| Type Disp | Equity |
| Volume | 1,518 |
| Website | https://www.vyometx.com |
| Zip | 2,138 |